Related Experiment Video

Updated: Jan 6, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K

Marked neurological recovery in aquaporin-4 neuromyelitis optica spectrum disorder (NMOSD) after delayed

P Peydro Lavoie1,2, A Attal3, A Lannuzel2,4,5,6,7

  • 1Department of Neurology, Université Catholique de Louvain, Brussels, Belgium.

Journal of Neurology
|September 27, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AQP4-IgGAccumulating disabilityAnti-complement therapyEculizumabNMOSD

More Related Videos

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
05:45

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

24.1K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.5K

Related Experiment Videos

Last Updated: Jan 6, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K
Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
05:45

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

24.1K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.5K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K

Articles linked to this work by shared authors, journal, and citation graph.

Peripheral Immunological Signatures of Parkinsonism: Insights from the Caribbean vs. North America.

Molecular neurobiology·2026

Temporal Association Between Dengue Outbreaks and Neurologic Autoimmune Diseases in French Guiana.

Neurology(R) neuroimmunology & neuroinflammation·2025

Early intensive therapy versus escalation strategy in French Caribbean multiple sclerosis cohort.

European journal of neurology·2025

Mitoxantrone in NMO Spectrum Disorder in a Large Multicenter Cohort in French Caribbean.

Neurology(R) neuroimmunology & neuroinflammation·2023

Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes.

Revue neurologique·2023

Olfactory outcomes in Zika virus-associated Guillain-Barré syndrome.

European journal of neurology·2022

Interlocking pentagons task and visuospatial deficit in parkinsonian syndrome: a quantitative approach.

Journal of neurology·2026

Intravenous thrombolysis use before interhospital transfer for thrombectomy: a systematic review and meta-analysis.

Journal of neurology·2026

Progressive motor impairment from intracerebral critical demyelinating lesions.

Journal of neurology·2026

Evaluating the neurofilament light chain-derived gap between biological and chronological age in multiple sclerosis and controls.

Journal of neurology·2026

The role of leukocyte p38 MAP kinase in immune-mediated peripheral polyneuropathies: distinct modulation by intravenous immunoglobulins.

Journal of neurology·2026

Real-space navigation in patients with focal epilepsy underpins the prominent role of the hippocampus for allocentric navigation in humans.

Journal of neurology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us